Skip to main content
. 2022 May 4;14(5):987. doi: 10.3390/pharmaceutics14050987

Figure 2.

Figure 2

Schematic illustration summarizing some of the major neurological disorders associated with impairment of the BBB. Reprinted from Ref. [25], MDPI, 2021.